IBAB Ion Beam Applications SA

IBA – TRANSPARENCY NOTIFICATION

IBA – TRANSPARENCY NOTIFICATION

(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)

Louvain-la-Neuve, Belgium, September 10, 2025 06:00 PM

Summary of the notification

IBA (Ion Beam Applications), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on September 3, 2025.

In its notification, Marcel Jo Maschmeyer indicated that following an acquisition or disposal of securities or voting rights, the 2% threshold has been crossed downwards by Paladin Asset Management, a controlled undertaking of Marcel Jo Maschmeyer on 09-01-2025.

Content of the notification

  • Reason for the notification: Acquisition or disposal of voting securities or voting rights, and downward crossing of the lowest threshold
  • Notification by: A parent company or controlling person
  • Persons subject to the notification requirement:
NameAddress (for legal entities)
Paladin Asset Management Investmentaktiengesellschaft mit veränderlichem Kapital und TeilgesellschaftsvermögenLister Straße 6, 30163 Hannover / Germany
Marcel Jo Maschmeyer 
  • Date on which the threshold is crossed: 09-01-2025
  • Threshold crossed (in %) : 2%
  • Denominator : 40.516.629
  • Notified details: (extract of the received notification form)
A) Voting rightsPrevious notificationAfter the transaction
 # of voting rights# of voting rights% of voting rights
Holders of voting rights Linked to securitiesNot linked

to the securities
Linked to securitiesNot linked to the securities
Marcel Maschmeyer00 0.00%0.00%
Paladin Asset Management Investmentaktiengesellschaft mit veränderlichem Kapital und Teilgesellschaftsvermögen768.765806.569 1.99% 
Subtotal768.765806.569 1.99% 
TOTAL806.569 1.99% 



B) Equivalent financial instrumentsAfter the transaction
Holders of equivalent financial instrumentsType of financial instrumentExpiration dateExercise period or date# of voting rights that may be acquired if the instrument is exercised% of voting rightsSettlement
       
TOTAL   



 



TOTAL (A & B)
 



# of voting rights
 



% of voting rights
 806.5691.99%
  • Full chain of controlled undertakings through which the holding is effectively held

Paladin Asset Management is controlled by Marcel Maschmeyer.

  • Additional information

Paladin Asset Management Investmentaktiengesellschaft mit veränderlichem Kapital und Teilgesellschaftsvermögen is the investment management company that can exercise the voting rights at its discretion, in the absence of specific instructions.

The 2% threshold, as stipulated in the Articles of Association, has been crossed downwards by Paladin Asset Management, a controlled undertaking of Marcel Jo Maschmeyer.

About IBA

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the fields of proton therapy, considered as the most advanced form of radiation therapy available today, as well as industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,100 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can be found at:

For further information, please contact:

Elena De Landy

Paralegal: Corporate Affairs and Insurance 

Attachment



EN
10/09/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ion Beam Applications SA

 PRESS RELEASE

IBA – TRANSPARENCY NOTIFICATION

IBA – TRANSPARENCY NOTIFICATION (Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, September 10, 2025 06:00 PM Summary of the notification IBA (Ion Beam Applications), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on September 3, 2025. In its notification, Marcel Jo Maschmeyer ind...

 PRESS RELEASE

IBA SA – NOTIFICATION TRANSPARENCE

IBA SA – NOTIFICATION TRANSPARENCE (article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 10 septembre 2025, 18:00 Résumé de la notification IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce devoir effectuer une notification en matière de transparence conformément à l'article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes (« loi transparence »), à la suite d’une notification reçu...

Michiel Declercq
  • Michiel Declercq

IBA 1H25 Conference call feedback & model update

IBA reported good 1H25 results, with revenues up 40% to € 304.9m (kbcse: € 274.6m) driven by strong backlog conversion in PT as well as OA. However, as most of the conversion relates to legacy lower margin contracts in Spain and China, the gross profit increase of +27% to € 90.0m (kbcse: € 93.4m) and REBIT of € 10.6m (kbcse: € 10.3m) were broadly in line with our estimates. However net cash significantly deteriorated on the back of WC investments, as anticipated. We are pleased to see IBA reiter...

ING Helpdesk
  • ING Helpdesk

REVISED VERSION - Benelux Morning Notes - updated to include IBA news

CFE: 1H results a bit light, FY outlook maintained. CMB.TECH: VLCC reasonable, pressure on Dry Bulk rates. dsm-firmenich: Givaudan CMD; Strategy 2030. Gimv: Investing in specialised healthcare services in the Netherlands. IBA: More sales but at lower margin

Hilde Van Boxstael ... (+6)
  • Hilde Van Boxstael
  • Kristof Samoy
  • Livio Luyten
  • Lynn Hautekeete
  • Michiel Declercq
  • Wim Lewi

ResearchPool Subscriptions

Get the most out of your insights

Get in touch